Sharon Maxwell, NP-C · Founder

Peptide Therapy in Draper, Utah: An Honest 2026 Guide to BPC-157, GHK-Cu, MOTS-C, Ipamorelin, and the FDA Question Everyone's Avoiding

By Sharon Maxwell, NP-C — Founder, Elements Med LoungeReviewed by Richard Maxwell, MD — Medical Director, Elements Med LoungePublished

Short answer: Peptide therapy is a real, evidence-supported area of regenerative medicine that has been partially blown up by the FDA's 2023–2025 regulatory changes. Some peptides remain legitimately available through licensed 503A compounding pharmacies under direct physician oversight. Others — including the most popular peptide on the internet, BPC-157 — were moved to the FDA's "do not compound" list in 2023, which means any practice still offering it is operating in a gray zone you should understand before you accept an injection. Pricing for legitimate peptide protocols in Utah runs $150–$600/month depending on the peptide, dose, and oversight model.

I'm Sharon Maxwell, NP-C, founder of Elements Med Lounge in Draper, Utah. Our regenerative protocols — including peptide therapy — are medically directed by Dr. Richard Maxwell. This article is the conversation we have with every new peptide patient.


What Peptides Actually Are

Peptides are short chains of amino acids — typically 2 to 50 amino acids long, sitting between an individual amino acid and a full protein. Your body makes thousands of them natively. They act as signaling molecules: they bind to specific cell-surface receptors and tell cells to do specific things — heal, build, secrete a hormone, modulate inflammation, induce sleep.

Therapeutic peptides are either:

  • Synthetic copies of peptides your body already makes (e.g., GHK-Cu, Thymosin Beta-4)
  • Engineered analogues of natural peptides, modified for stability or potency (e.g., Tesamorelin, the GLP-1 family)
  • Patented modifications developed in research labs (e.g., BPC-157, originally isolated from gastric juice)

Peptides are not steroids, not hormones in the testosterone/estrogen sense, and not "miracle drugs." They are precise signaling molecules with real but specific effects.


The FDA Regulatory Picture You Need to Understand

This is the part most clinics don't tell you. As of 2026:

FDA-approved peptide drugs

A handful of peptides are full FDA-approved medications: Tesamorelin (HIV-related lipodystrophy, marketed as Egrifta), Sermorelin (no longer commercially manufactured), Semaglutide and Tirzepatide (GLP-1s for diabetes and weight loss), among others. These are normal prescription drugs.

Peptides available through 503A compounding pharmacies

Many peptides commonly used in regenerative medicine are not FDA-approved as drugs but can legally be compounded by licensed 503A pharmacies based on individual patient prescriptions, under physician supervision. As of late 2024, the FDA narrowed this list significantly. Peptides currently understood to be compoundable include (subject to change):

  • GHK-Cu (copper peptide) — for skin and tissue
  • CJC-1295 / Ipamorelin — growth hormone secretagogues (with caveats)
  • MOTS-C — mitochondrial peptide
  • Thymosin Alpha-1 — immune modulator (with restrictions)
  • Selank, Semax — nootropic peptides (variable availability)

Peptides on the FDA's "do not compound" list (Category 2)

In late 2023, the FDA placed several popular peptides on the "Category 2 – significant safety risks" list, meaning 503A pharmacies are not supposed to compound them. The most notable on that list:

  • BPC-157
  • Thymosin Beta-4 (TB-500)
  • Epitalon
  • Several others

This is the part that matters for your safety: if a clinic is selling you BPC-157 in 2026, the source is almost certainly either (a) a research-grade vendor selling material marked "not for human use," (b) an overseas pharmacy, or (c) a 503A pharmacy operating against FDA guidance. None of those are clean. We won't pretend the 503A bench is empty when it's not, but we also won't pretend the FDA situation around BPC-157 is settled when it isn't.

Our practice's position: we follow current 503A guidance. Where peptides are clearly compoundable under physician oversight, we offer them. Where the FDA has placed peptides on the "do not compound" list, we discuss the regulatory status honestly with patients and document informed consent. If we're not comfortable with the sourcing, we don't dispense.


What the Evidence Actually Says (Peptide by Peptide)

Honest read of the literature as of 2026:

PeptideBest-supported useEvidence qualityCompoundable?
Tesamorelin (Rx)HIV lipodystrophy, possibly NAFLDFDA-approved, strongn/a (Rx)
Sermorelin / CJC-1295 + IpamorelinAdult GH secretagogue, sleep, recoveryModerate, mostly small studiesYes (with caveats)
GHK-CuTopical skin healing, hair density (topical)Moderate (topical); thin (injection)Yes
MOTS-CMetabolic, mitochondrial — animal models strongThin human dataYes (currently)
Thymosin Alpha-1Immune modulation, hepatitis-B adjunctModerateRestricted
BPC-157Tendon, ligament, gut healing — animal modelsAlmost no human RCT dataNo (FDA Cat. 2)
Thymosin Beta-4 (TB-500)Wound healing — animal modelsNo human RCT dataNo (FDA Cat. 2)
Semaglutide / Tirzepatide (Rx)Weight loss, T2DFDA-approved, strongn/a (Rx)

The honest summary: the peptides with the most credible benefits in 2026 are the ones that are also FDA-approved drugs (Tesamorelin, the GLP-1 family). The ones the internet is most excited about (BPC-157, TB-500) have the weakest human evidence and the most regulatory friction.


How Much Does Peptide Therapy Cost in Utah?

Direct answer: legitimate 503A-sourced peptide protocols run $150–$600 per month in Utah, depending on the peptide(s), dose, and the level of physician oversight included in the price. Initial workup (consult + labs) adds $300–$800 one-time.

FormatTypical monthly cost
Single peptide (e.g., GHK-Cu monotherapy)$150–$250/mo
Growth hormone secretagogue (Ipamorelin + CJC-1295)$250–$400/mo
Multi-peptide stack with quarterly labs$400–$600/mo
Initial intake + labs (one-time)$300–$800

Why the range: sourcing (503A pharmacy quality varies), oversight model (telehealth-only "peptide subscription" services charge less but offer less; in-person practices with quarterly labs charge more), and dose. Be skeptical of anything under $100/month for "everything you need" — that pricing implies under-dosing or unverified sourcing.

Insurance: peptides are not covered, with the exception of FDA-approved peptide drugs (Tesamorelin, Semaglutide for diabetes, etc.) which may be covered with appropriate diagnosis codes.


What Supervised Peptide Therapy Should Look Like

Whether you choose Elements or any other practice, here's the standard you should hold a peptide clinic to:

1. Comprehensive intake

Real medical history, current medications, family history of cancer (peptides that stimulate growth signaling are not appropriate for everyone), reproductive plans.

2. Baseline labs before any peptide

At minimum: CBC, comprehensive metabolic panel, IGF-1, hormone panel relevant to the peptide, sometimes additional markers. Don't accept a peptide prescription from a clinic that didn't draw your blood first.

3. Sourced from a licensed 503A compounding pharmacy

You should be able to ask which pharmacy compounds your peptides. The answer should be a specific licensed U.S. compounding pharmacy with verifiable accreditation (PCAB, USP-797, USP-800). "Our pharmacy partner" with no name is a red flag.

4. Documented informed consent

Particularly for peptides in regulatory gray zones, you should sign a document acknowledging the off-label or non-FDA-approved status and the known risks.

5. Follow-up labs at 8–12 weeks

Real protocols recheck IGF-1, fasting glucose, hormone markers, and any peptide-specific monitoring. If a clinic prescribes peptides indefinitely with no follow-up labs, leave.

6. A clinician who can answer "why this peptide, why this dose, why now"

Not "the package we recommend for everyone."


Who Peptide Therapy Is (And Isn't) Appropriate For

Reasonable candidates:

  • Adults 30+ with documented declining IGF-1, recovery, or specific tissue issues
  • Recovery from documented injury, post-surgical
  • Athletes managing recovery (with the understanding that some peptides may show on competition drug panels)
  • Adults exploring longevity-focused protocols after foundational health is dialed in (sleep, training, nutrition, labs in range)

Not appropriate candidates:

  • Pregnancy or breastfeeding
  • History of any active or recently treated cancer (growth signaling peptides are contraindicated)
  • Untreated diabetic retinopathy (for GH secretagogues)
  • Anyone using peptides as a substitute for evidence-based care for a diagnosed condition
  • Anyone whose foundational health (sleep, training, nutrition, labs) is wildly out of range — fix that first

Frequently Asked Questions

Is peptide therapy legal in 2026?

Legal status depends on the specific peptide. FDA-approved peptide drugs (Tesamorelin, Semaglutide, Tirzepatide, etc.) are normal prescription medications. Peptides legitimately compoundable under 503A guidance (GHK-Cu, sermorelin-family peptides, MOTS-C, etc., subject to changing FDA lists) can be obtained legally with a prescription. Peptides on the FDA's Category 2 "do not compound" list (BPC-157, TB-500, others) are in a regulatory gray zone and the legal/safety picture is less clear.

Why do online "peptide vendors" sell BPC-157 if it's restricted?

The vast majority of online peptide vendors sell material labeled "for research use only — not for human consumption" — which lets them operate outside FDA jurisdiction for human-drug compounding. People then inject it anyway. This is the bulk of the BPC-157 market and it's not safe: sourcing, purity, sterility, dose accuracy, and freedom from endotoxin are all uncontrolled. Don't do this.

How long does it take to feel peptide effects?

Depends on the peptide. GH secretagogues (Ipamorelin/CJC-1295): sleep changes often in the first week, body-composition changes over 8–12 weeks. GHK-Cu: skin and hair changes over 4–8 weeks. MOTS-C: subjective energy changes commonly in week 2–4, metabolic markers shift over 8–12 weeks. Some patients respond, some don't.

Are peptides anabolic steroids?

No. Anabolic steroids are testosterone analogues that directly stimulate muscle protein synthesis at supraphysiologic levels. Most therapeutic peptides are signaling molecules at near-physiologic doses. The exceptions blur — growth hormone secretagogues can shift IGF-1 upward, which has anabolic effects in the long run, but the mechanism and magnitude are entirely different from AAS.

Will peptides make me test positive for performance-enhancing drugs?

Many peptides used in regenerative medicine — including growth hormone secretagogues — are on WADA and USADA prohibited lists. If you compete in any sanctioned sport, do not start peptide therapy without checking against the current prohibited list. We will not knowingly prescribe peptides to in-competition athletes.

What peptides do you offer at Elements?

We follow current 503A guidance and only prescribe peptides we can source from accredited compounding pharmacies with appropriate documentation. The specific peptides we offer change as the FDA list changes; we'll go through the current available options at your consult. We do not dispense peptides without baseline labs, informed consent, and a follow-up plan.

Can I just buy peptides online and inject them myself?

Legally, no — if the peptide is intended for human use. Practically, plenty of people do, and they're rolling the dice on purity, sterility, dose accuracy, and contamination. We have seen patients arrive with abscesses, endotoxin reactions, and worse from research-grade peptides. The "savings" aren't worth it.

How long should I stay on a peptide protocol?

Most therapeutic protocols run 8–12 weeks, often with cycling (on/off periods) for peptides that affect receptor sensitivity. Continuous indefinite use of any peptide is a red flag — both for receptor down-regulation and for clinic motives.


Why This Article Exists

Most peptide-clinic websites in 2026 either pretend the FDA situation doesn't exist or quietly stopped offering peptides without explaining why. Patients deserve the honest version: which peptides have evidence, which are in a regulatory gray zone, what supervised therapy actually looks like, and what questions to ask before any clinic puts a peptide in your hand.

Book a free 15-minute peptide screening consult at Elements Med Lounge: elementsmedlounge.com/contact · (801) 860-4134 · 11576 S. State Street, Suite 101B, Draper, UT.


Sharon Maxwell, NP-C is the founder and clinical lead of Elements Med Lounge in Draper, Utah. Regenerative medicine protocols are medically directed by Richard Maxwell, MD, board-certified physician. This article is informational, reflects the FDA regulatory landscape as of May 2026, and is not a substitute for in-person medical evaluation. Peptide availability and regulatory status change frequently — confirm current information at your consult.